Trial Profile
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Efficacy, Safety, and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 22 May 2013
Price :
$35
*
At a glance
- Drugs Perampanel (Primary)
- Indications Parkinson's disease
- Focus Registrational; Therapeutic Use
- 09 Dec 2011 Primary endpoint 'Off-time' has not been met.
- 10 Apr 2008 Status changed from in progress to completed as reported by Eisai.
- 10 Apr 2008 Primary endpoint not met, as reported in an Eisai media release.